Monday, July 26, 2021 12:39:37 PM
He was named one of the world's top 3% scientists four years in a row. The National Cancer Center selected Dr. Lee as "The Outstanding Scientist of the Year." He has published over 200 research papers, with approximately 90 through the Science Citation Index (SCI).
His research includes CBD research and SCI international cancer research papers. He developed a cancer drug using natural products, small molecular compounds and antibodies. Dr. Lee has fifteen registered patents.
Dr. Lee has brought to Kaiyon Biotech Inc. a consortium of prestigious scientists and researchers that share in his mission to discover, formulate, and license psilocybin and CBD medicines to be used in the treatment of dementia, schizophrenia, manic depression, sleep disorder, PTSD, cancer and autism.
According to Dr. Lee, the scientists hired at Kaiyon Biotech are each strategic for their contribution to research, and there is KFDA approval for studying psilocybin and CBD.
Dr. DaeHee Lee received a Master of Science and Doctorate of Philosophy in biotechnology and food science from Korea University at Seoul.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM